Abstract
Lentiviral Hematopoietic Stem and Progenitor Cell Gene Therapy for Wiskott-Aldrich Syndrome (WAS): Up to 8 Years of Follow up in 17 Subjects Treated Since 2010
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have